3.980USD+2.31%Mkt Cap: 214.46M USDP/E: —Last update: 2026-05-26
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary …
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap214.46M USD
Enterprise Value217.53M USD
Revenue (TTM)41.80M USD
Gross Profit13.44M USD
Net Income (TTM)-17.26M USD
Revenue/Share0.7810 USD
Last Price3.980 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees158
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-15.80
PEG—
EV/EBITDA-22.97
EV/Revenue5.20
P/S4.96
P/B3.01
EPS (TTM)-0.31
EPS (Forward)-0.24
52W Range
1.91043% of range6.680
52W High6.680 USD
52W Low1.910 USD
Profitability
Gross Margin33.17%
Oper. Margin-38.80%
EBITDA Margin-22.66%
Profit Margin-42.59%
ROE-25.09%
ROA-16.66%
Growth
Revenue Growth13.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.65M USD
CapEx (TTM)1.15M USD
FCF Margin-5.71%
FCF Yield-1.11%
Net Debt10.04M USD
Net Debt/EBITDA-1.06
Balance Sheet
Debt/Equity0.41
Current Ratio4.59
Quick Ratio3.40
Book Value/Sh1.284 USD
Cash/Share0.3320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)9.000 USD
Target Range7.000 USD – 12.00 USD
# Analysts3
Ownership
Shares Out.53.61M
Float10.88M
Insiders9.32%
Institutions84.72%
Short Interest
Short Ratio12.0d
Short % Float12.02%
Short % Out.2.45%
Shares Short1.31M
Short (prev mo.)1.35M
Technical
SMA 503.189 (+24.8%)
SMA 2003.926 (+1.4%)
Beta0.47
S&P 52W Chg28.31%
Avg Vol (30d)107.84K
Avg Vol (10d)104.98K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—